“BRAND EQUITY AND COUNTRY OF ORIGIN MODEL IN PHARMACEUTICAL INDUSTRY”, AJBMR, vol. 3, no. 6, pp. 137–146, Feb. 2014, doi: 10.65453/ajbmr.v3i6.554.